CARDIOPLEGIA SOLUTION A (solution) | 合法醫療器材資訊網

Physiology[edit] ... Cardioplegic solution is the means by which the ischemic myocardium is protected from cell death. This is achieved by reducing myocardial​ ... Read More

由 C Carvajal 著作 · 2021 — [1] Cardioplegia varies by composition, delivery methods, temperature, and additives; however, all solutions must include potassium chloride (15- ... Read More

由 M Sobieraj 著作 · 2018 · 被引用 6 次 — Cardioplegic solutions type influences postoperative variables in children after heart surgery by the negative impact of crystalloid cardioplegia. Read More

由 ST Buel 著作 · 2016 · 被引用 20 次 — There are many cardioplegia solutions currently in use for pediatric cardiopulmonary bypass (CPB). The most common being del Nido solution. Read More

Baxter Cardioplegic Solution is a sterile, nonpyrogenic, essentially isotonic, formulation of electrolytes in Water for Injection, USP. It is a “core solution” intended ... Read More

由 AJ Donnelly 著作 · 1991 · 被引用 26 次 — Basic characteristics of cardioplegia solutions include temperature, osmolarity, and pH. Crystalloid solution has traditionally been used as a vehicle for ... Read More

Cardioplegia Solution A is a sterile, non-pyrogenic solution for cardiac perfusion in a Viaflex bag. It is used to induce cardiac stasis and to protect the myocardium​ ... Read More

由 GD Buckberg 著作 · 2016 · 被引用 22 次 — Two goals of a cardiac surgical procedure are technical excellence and protection of cardiac function. Cardioplegia is used, almost universally, to ... Read More

並列篇名. Dilong and Lumbrokinase prevent the High-KCL Cardioplegic Solution Administration Induced Apoptosis and Fibrosis in H9c2 cardiomyoblast cells. Read More